SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-21-000175
Filing Date
2021-08-11
Accepted
2021-08-11 16:23:09
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-20210630.htm   iXBRL 10-Q 1537836
2 EX-31.1 evfm-6302021xex311.htm EX-31.1 19833
3 EX-31.2 evfm-6302021xex312.htm EX-31.2 19730
4 EX-32.1 evfm-6302021xex321.htm EX-32.1 10910
  Complete submission text file 0001618835-21-000175.txt   7714160

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20210630.xsd EX-101.SCH 51474
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20210630_cal.xml EX-101.CAL 69244
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20210630_def.xml EX-101.DEF 317360
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20210630_lab.xml EX-101.LAB 662402
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20210630_pre.xml EX-101.PRE 443480
10 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20210630_htm.xml XML 1331794
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 211163728
SIC: 2834 Pharmaceutical Preparations